GlassScriptPhysician profile
Jada J Reese
NPI 1497928600
$4,287.33
in general payments reported to CMS, 2019-2025
28 companies · $620 in 2025
The $620 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $215 · 2021: $677 · 2022: $650 · 2023: $503 · 2024: $1,213 · 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,335.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,629.15 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Nevro Corp. | $581.31 | 2021-2024 | Senza |
| Abbvie INC. | $233.88 | 2022-2025 | |
| Biotronik Nro, INC. | $195.67 | 2024-2025 | Prospera |
| Allergan, INC. | $194.15 | 2019-2022 | |
| Electronic Waveform Lab, INC. | $174.15 | 2025 | |
| Medtronic, INC. | $169.32 | 2022-2023 | Intellis Adaptivestim |
| Pfizer INC. | $154.06 | 2019-2021 | |
| Ibsa Pharma INC. | $115.72 | 2023-2024 | Tirosint, Licart, Tirosint |
| Si-Bone, INC. | $87.69 | 2025 | |
| Medtronic USA, INC. | $84.46 | 2019 | |
| Abbott Laboratories | $74.94 | 2019-2024 | Proclaim |
| Daiichi Sankyo INC. | $72.23 | 2019 | |
| Lilly USA, LLC | $53.98 | 2020-2022 | |
| Tersera Therapeutics LLC | $51.52 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $51.07 | 2020-2021 | |
| Globus Medical, INC. | $45.93 | 2025 | Senza |
| Alnylam Pharmaceuticals INC. | $44.71 | 2024-2025 | Amvuttra |
| Biohaven Pharmaceuticals, INC. | $44.30 | 2021 | |
| Forte Bio-Pharma LLC | $41.34 | 2020-2021 | |
| Mdd US Operations, LLC | $32.77 | 2019 | |
| Stryker Corporation | $32.09 | 2022 | |
| Avanos Medical | $30.66 | 2024 | Standard Rf Disposables |
| Averitas Pharma INC. | $21.06 | 2023 | Qutenza |
| Novartis Pharmaceuticals Corporation | $19.71 | 2020 | |
| Grt US Holding, INC. | $18.45 | 2020 | |
| Saluda Medical Americas, INC. | $17.12 | 2025 | Evoke |
| Kowa Pharmaceuticals America, INC. | $15.89 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jada Reese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.